Ridaforolimus Comprehensive patent search

We are sorry but this premium report expired!

This market research, not available anymore on the publisher's website, was withdrawn from our database.

To get an alternative report, you can either :

  • Have a look at the list of documents hereafter
  • Launch a new search below

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

DOWNLOAD THESE REPORTS NOW!

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Serbia Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2015
  • 122 pages

BMI View: Despite a downgrade in our economic outlook for Serbia, BMI's expenditure projections for the pharmaceutical industry for from 2012 to 2015 are up moderately due to revisions to our previous expectation that drugmakers will take action to reduce their exposure in the industry because of the ...

Industries: Generic Drug | Countries: Serbia and Montenegro

World Generic Markets 05 JANUARY 2015

World Generic Markets 05 JANUARY 2015

  • $ 1 114
  • Industry report
  • by Espicom Business Intelligence
  • January 2015
  • 20 pages

Industry Trend Analysis - National And International Legislation To Mould Generic Industry In 2015 Industry Brief - Teva Launches Erlotinib In Canada Industry Brief - Par Adds Name To Trokendi XR Patent Challengers Industry Brief - Teva, Actavis Launch Celecoxib In US Industry Brief - Mylan Gains Tentative ...

Industries: Generic Drug | Countries: World, United States

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

Mexico Pharmaceuticals and Healthcare Industry Update Quarter 1 2012

  • $ 1 300
  • Industry report
  • by Business Monitor International
  • January 2015
  • 137 pages

BMI View: Despite our generally positive outlook for much of Latin America in 2012, we maintain the view that mounting fiscal pressures and a faltering business environment will damage Mexico’s attractiveness to multinational drugmakers Beyond ongoing policy concerns, we believe consumer acceptance ...

Industries: Generic Drug | Countries: Mexico

International Directory of Generics Companies 2015

International Directory of Generics Companies 2015

  • $ 275
  • Industry report
  • by Asia Pacific Infoserv
  • January 2015
  • 200 pages

The most comprehensive and accurate Directory of companies and executives in the generics industry Internationally

Industries: Generic Drug

Generic Pharmaceuticals Global - Industry Report

Generic Pharmaceuticals Global - Industry Report

  • $ 1 668
  • Industry report
  • by Plimsoll Publishing Ltd UK
  • January 2015
  • 200 pages

Plimsoll's GENERIC PHARMACEUTICALS (Global) analysis is the most definitive and accurate study of the GENERIC PHARMACEUTICALS (Global) sector in 2013. The report is split into two sections and uses both a written and graphical analysis - analysing the 200 largest GENERIC PHARMACEUTICALS (Global) companies. ...

Industries: Generic Drug | Countries: World

Fesoterodine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Fesoterodine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • by Ark Patent Intelligence
  • January 2015

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Frovatriptan  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Frovatriptan - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • by Ark Patent Intelligence
  • January 2015

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Galantamine  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Galantamine - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • by Ark Patent Intelligence
  • January 2015

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Ibandronic Acid  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Ibandronic Acid - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • by Ark Patent Intelligence
  • January 2015

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States, World

Imatinib  - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

Imatinib - Patent, Extension and Data Exclusivity Expiry Snapshot (9 countries)

  • $ 653
  • Industry report
  • by Ark Patent Intelligence
  • January 2015

Need fast access to comprehensive SPC, data exclusivity, and litigation intelligence that's simple to access and use? Already used by big pharma, biologics manufacturers and their law firms, Patent, Extension and Data Exclusivity Expiry Snapshot saves you days of research and instantly puts you in-the-know. ...

Industries: Generic Drug | Countries: United Kingdom, Australia, Canada, Spain, Italy, France, Germany, Japan, Europe, United States

24/7 Customer Service

You can call our customer service 24 hours a day / 7 days a week

  • +1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.